{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05935384",
            "orgStudyIdInfo": {
                "id": "06-MX-001"
            },
            "organization": {
                "fullName": "Guardant Health, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation",
            "officialTitle": "SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "sibyl-observation-of-therapy-response-with-liquid-biopsy-evaluation"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-29",
            "studyFirstSubmitQcDate": "2023-06-29",
            "studyFirstPostDateStruct": {
                "date": "2023-07-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-17",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Guardant Health, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of SIBYL is to generate clinical validity data for the ability of a future version of Guardant360 developed by Guardant Health to measure response to systemic therapy in patients with unresectable advanced solid tumors. It is necessary to collect clinical data points and treatment outcomes in order to demonstrate clinical validity for longitudinal monitoring with ctDNA and correlation of ctDNA dynamics with therapeutic response, as evaluated by standard methods, including RECIST 1.1 and CT scan measurements."
        },
        "conditionsModule": {
            "conditions": [
                "Non-small Cell Lung Cancer",
                "Colorectal Cancer",
                "Breast Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 440,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1: Unresectable Stage III/IV NSCLC",
                    "description": "Blood samples collected will be banked",
                    "interventionNames": [
                        "Diagnostic Test: Guardant360"
                    ]
                },
                {
                    "label": "Cohort 2: Stage IV Colorectal",
                    "description": "Blood samples collected will be banked",
                    "interventionNames": [
                        "Diagnostic Test: Guardant360"
                    ]
                },
                {
                    "label": "Cohort 3: Unresectable Stage III/IV Breast - HR+ HER2-",
                    "description": "Blood samples collected will be banked",
                    "interventionNames": [
                        "Diagnostic Test: Guardant360"
                    ]
                },
                {
                    "label": "Cohort 4: Unresectable Stage III/IV Breast - HR- HER2+",
                    "description": "Blood samples collected will be banked",
                    "interventionNames": [
                        "Diagnostic Test: Guardant360"
                    ]
                },
                {
                    "label": "Cohort 5: Unresectable Stage III/IV Breast - Triple Positive",
                    "description": "Blood samples collected will be banked",
                    "interventionNames": [
                        "Diagnostic Test: Guardant360"
                    ]
                },
                {
                    "label": "Cohort 6: Unresectable Stage III/IV Breast - Triple Negative",
                    "description": "Blood samples collected will be banked",
                    "interventionNames": [
                        "Diagnostic Test: Guardant360"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Guardant360",
                    "description": "Guardant360 is a qualitative next generation sequencing (NGS)-based in vitro diagnostic device for detection of single nucleotide variants (SNVs), insertions and deletions (indels), copy number amplifications (CNAs), and fusions in genes frequently mutated in cancer, using circulating cell-free DNA (cfDNA) obtained from the plasma of peripheral whole blood collected in Streck Cell-Free DNA Blood Collection Tubes.",
                    "armGroupLabels": [
                        "Cohort 1: Unresectable Stage III/IV NSCLC",
                        "Cohort 2: Stage IV Colorectal",
                        "Cohort 3: Unresectable Stage III/IV Breast - HR+ HER2-",
                        "Cohort 4: Unresectable Stage III/IV Breast - HR- HER2+",
                        "Cohort 5: Unresectable Stage III/IV Breast - Triple Positive",
                        "Cohort 6: Unresectable Stage III/IV Breast - Triple Negative"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Sensitivity of ctDNA to Detect Disease Progression",
                    "description": "The Primary Endpoint, sensitivity of ctDNA to detect disease progression, will be evaluated from all eligible subjects within the primary study cohorts (breast cancer, NSCLC, or CRC)",
                    "timeFrame": "6 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "RECIST Response",
                    "description": "RECIST v1.1 response: defined as the tumor response to treatment as measured by restaging scans in subjects who have increasing or decreasing ctDNA quantities before the time of scan and correlating this change with the clinical response",
                    "timeFrame": "6 years"
                },
                {
                    "measure": "Progression-Free Survival (PFS)",
                    "description": "PFS: defined as the quantitative changes in ctDNA that correlate or associate with participant's progression free survival on each line of SOC therapy",
                    "timeFrame": "6 years"
                },
                {
                    "measure": "Lead Time",
                    "description": "Lead time: defined as the interval between ctDNA detection or increase and clinical detection of disease progression",
                    "timeFrame": "6 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "* Will be treated with a first- or second-line systemic and/or oral standard of care regimen at the enrolling site\n* Patient is either treatment naive and has not yet commenced first line SOC therapy OR patient has completed a prior line of SOC therapy and will commence subsequent line of SOC therapy\n* Provide written informed consent to participate in the study\n* Diagnosed with an unresectable advanced solid malignancy and have a histologically confirmed cancer that qualifies for inclusion, defined as:\n\n  * Non-small cell lung cancer (stage III-IV)\n  * Colorectal adenocarcinoma (stage III-IV)\n  * Breast Cancer (stage III-IV)\n\nExclusion Criteria:\n\n* History of a prior solid or hematological malignancy within 5 years of enrollment\n* Life expectancy \\< 12 weeks\n* Unable to collect baseline blood sample prior to starting SOC regimen\n* Is participating in an interventional clinical trial or another observational study that is evaluating the performance of another genomic test for detecting/predicting clinical response/progression",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The primary study population will include participants with Non-small cell lung cancer (stage III-IV), Colorectal adenocarcinoma (stage III-IV), and Breast Cancer (stage III-IV), as per inclusion/exclusion criteria. Approximately 440 total patients will be enrolled into the study.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trial Operations",
                    "role": "CONTACT",
                    "phone": "8556988887",
                    "email": "sibyl@guardanthealth.com"
                }
            ],
            "locations": [
                {
                    "facility": "Orchard Healthcare Research Inc.",
                    "status": "RECRUITING",
                    "city": "Skokie",
                    "state": "Illinois",
                    "zip": "60077-1384",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ira Oliff",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.03336,
                        "lon": -87.73339
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                },
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000012002",
                    "term": "Rectal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "asFound": "Colorectal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14844",
                    "name": "Rectal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}